Q2 FY2026 · ended Jun 30, 2026 · Revenue $7.67M, -12.8% YoY · Filed Aug 12, 2026
Stereotaxis, Inc. (STXS) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $7.7 million and a net loss of $4.5 million. Free cash flow was -$3.7 million. As of Jun 30, 2026 it held $10.5 million in cash and investments and $5.2 million in total debt.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- STXS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- St.Louis, MO
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1289340
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $7.7M | $6.3M | $8.6M | $7.5M | $8.8M |
| Operating income | -$4.6M | -$6.0M | -$5.6M | -$6.6M | -$4.0M |
| Net income | -$4.5M | -$5.9M | -$5.5M | -$6.5M | -$3.8M |
| Diluted EPS | -$0.05 | -$0.06 | -$0.06 | -$0.07 | -$0.05 |
| Operating cash flow | -$3.7M | -$3.4M | -$4.0M | -$4.2M | -$3.7M |
| Free cash flow | -$3.7M | -$3.5M | -$4.0M | -$4.2M | -$3.8M |
| Total assets | $55.6M | $54.0M | $52.3M | $45.6M | $41.2M |
| Total liabilities | $38.1M | $34.4M | $33.5M | $34.1M | $34.4M |
| Stockholders' equity | $12.2M | $14.4M | $13.5M | $6.3M | $1.5M |
| Cash and investments | $10.5M | $14.6M | $13.4M | $10.5M | $7.0M |
| Total debt | $5.2M | $5.3M | $5.4M | $5.6M | $5.7M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Other events
|
Jul 16, 2026 | Jul 15, 2026 |
| 8-K |
Current report
Unregistered share sale, Regulation FD disclosure, Other events
|
Jul 9, 2026 | Jul 7, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 15, 2026 | May 14, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
All 1003 Stereotaxis, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.